Clinical Trial Update: Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing intravenous omeprazole to ranitidine for preventing recurrent bleeding after endoscopic treatment of bleeding ulcers was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peptic Ulcers

Drugs mentioned

• Omeprazole (Omeprazole)
• Ranitidine (Ranitidine)

Snippet

Sponsor: Keio University | Conditions: Peptic Ulcers | Phase 4 | Status: WITHDRAWN